MILLET INNOVATION SA is a France-based company. It is a developer of medical and protective gear intended to cure orthopaedic and podiatric problems. The Company provides orthopaedic solutions such as joint, tendon, nerve, nail, and skin lesions, thereby providing comfort from disabling chronic pain. The Company distributes its products through its brand Epitact.

Employees

Sector

Drug Retailers

More about the company

Real-time Euronext Paris 10:30:11 2019-10-23 EDT			5-day change	1st Jan Change
20.20 ^EUR	-.--%		-.--%	+18.82%

21-12-09	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
20-09-17	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI

Market Cap	38.47M 34.37M 31.57M 28.67M 53.84M 3.64B 55.19M 377M 152M 1.92B 144M 141M 6.1B	P/E 2017	17.4x	P/E 2018	19.8x
Enterprise Value	36.72M 32.8M 30.13M 27.36M 51.39M 3.48B 52.68M 360M 145M 1.84B 138M 135M 5.82B	EV / Sales 2017	1.97x	EV / Sales 2018	1.38x
Free-Float	5.42%	Yield 2017	3.36%	Yield 2018	-

21-12-09	Millet Innovation SA Reports Earnings Results for the Half Year Ended June 30, 2021	CI
20-09-17	Curae Lab SARL cancelled the acquisition of remaining 12.5% stake in Millet Innovation SA from Holding Managers.	CI
19-09-17	Curae Lab SARL agreed to acquire remaining 12.5% stake in Millet Innovation SA from Holding Managers for €4.8 million.	CI

19-10-25	Millet Innovation : MILLET INNOVATION - MISE EN OEUVRE DU RETRAIT OBLIGATOIRE
19-10-09	Millet Innovation : Communiqué de mise à disposition des Autres informations
19-10-08	Millet Innovation : COMMUNIQUE DE MISE A DISPOSITION DE LA NOTE D’INFORMATION ETABLI PAR CURAE LAB
19-09-18	Millet Innovation : DEPOT PROJET DE NOTE D’INFORMATION EN REPONSE RELATIVE A L’OPAS
19-09-17	Millet Innovation : RAPPORT SEMESTRIEL AU 30/06/2019

Millet Innovation Stock

Stocks

ALINN

FR0010304402

Drug Retailers

Valuation: Millet Innovation

Latest news: Millet Innovation

News in other languages: Millet Innovation

Managers and Directors: Millet Innovation

Retail - Drugs without Grocery

Financials

Company Profile

Manager	Title	Age	Since
Damien Millet CEO	Chief Executive Officer	-	2002-12-08
Valérie Chopinet DFI	Director of Finance/CFO	-	2006-12-18

Director	Title	Age	Since
Jean-Claude Millet CHM	Chairman	-	1998-03-15
Pierre Martin BRD	Director/Board Member	-	1998-03-15
Jean-Paul Maingaud BRD	Director/Board Member	-	2011-03-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MILLET INNOVATION	-.--%	-.--%	-	-	42.79M
JD HEALTH INTERNATIONAL INC.	-0.20%	+9.93%	-34.11%	+3.38%	16.32B
TSURUHA HOLDINGS INC.	+2.15%	+8.24%	-13.50%	+7.22%	6.52B
MATSUKIYOCOCOKARA & CO.	+0.21%	+4.37%	-5.64%	+0.13%	6.51B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	0.00%	+5.91%	-48.43%	-40.66%	6.09B
RAIA DROGASIL S.A.	-2.37%	-7.93%	-23.56%	-40.26%	4.72B
YIFENG PHARMACY CHAIN CO., LTD.	+2.63%	+6.92%	+11.36%	-8.31%	4.97B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+1.80%	+13.20%	+15.26%	-16.19%	3.57B
NAHDI MEDICAL COMPANY	+0.61%	-0.60%	-21.35%	-32.50%	3.12B
SUGI HOLDINGS CO.,LTD.	+0.91%	+2.67%	-21.16%	+30.92%	3.08B
Average	+0.56%	+4.06%	-15.68%	-10.70%	5.49B
Weighted average by Cap.	+0.45%	+4.75%	-20.19%	-8.01%

	2017	2018
Net sales	21.86M 19.53M 17.94M 16.29M 30.59M 2.07B 31.36M 214M 86.14M 1.09B 82.05M 80.29M 3.46B	22.21M 19.84M 18.23M 16.55M 31.08M 2.1B 31.87M 218M 87.52M 1.11B 83.36M 81.58M 3.52B
Net income	2.54M 2.27M 2.09M 1.89M 3.56M 241M 3.65M 24.91M 10.02M 127M 9.54M 9.34M 403M	1.63M 1.46M 1.34M 1.22M 2.28M 155M 2.34M 15.99M 6.43M 81.62M 6.13M 6M 259M
Net Debt	-1.07M -952K -875K -794K -1.49M -101M -1.53M -10.44M -4.2M -53.28M -4M -3.91M -169M	-1.75M -1.57M -1.44M -1.31M -2.45M -166M -2.51M -17.17M -6.91M -87.61M -6.58M -6.44M -278M